Search
New MSK research showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and sheds new light on cell state changes in prostate cancer.
Recent data from Memorial Sloan Kettering shows that a real-time breast ultrasound exam after second opinion review of outside, static breast ultrasound images led to a change in the initially prescribed management in 32.5 percent of included patients.
Traveling with cancer can be done, even if you’re in active treatment. Plan ahead so that you can fully enjoy your vacation.
A major research initiative could pave the way for new stem cell therapies for people with damaged immune systems.
Memorial Sloan Kettering’s Melanoma Disease Management Team understands the importance of helping these patients maximize the opportunities and overcome the challenges that arise in their lives.
An MSK clinical trial found that participating in integrative therapy classes online could benefit cancer patients in active treatment, not only by reducing fatigue, anxiety, and depression but also lowering hospitalization rates.
En un ensayo clínico de MSK se descubrió que participar en clases de terapia integral en línea podría beneficiar a los pacientes que padecen cáncer y reciben tratamiento activo, no solo porque reduce la fatiga, la ansiedad y la depresión, sino también porque disminuye las tasas de hospitalización.
A gift from the estate of renowned fashion designer Geoffrey Beene will enable MSKCC to launch an ambitious research initiative to be known as the Geoffrey Beene Cancer Research Center.
Learn how MSK is Improving patients’ quality of life with less toxic treatments.
A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.